Relmada Therapeutics logo
Relmada Therapeutics RLMD
$ 2.82 2.55%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Relmada Therapeutics EV/EBITDA Ratio 2011-2024 | RLMD

Annual EV/EBITDA Ratio Relmada Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.91 -8.34 -3.53 -2.37 -1.17 -0.869 -2.92 -0.402 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.402 -8.34 -2.81